Earlypay Enters FY27 with a Larger Lending Portfolio and Growth Momentum
Source: Kapitales Research
Earlypay Limited (ASX: EPY) ended FY26 with solid portfolio expansion, although increased credit expenses and investment spending pressured profitability. Funds in Use reached AU$307.8 million in June 2026, up 23% year-on-year and marking its strongest level in more than three years. Net revenue increased 7% to AU$36.0 million, while underlying NPAT fell 29% to AU$3.7 million.Equipment Finance was a major contributor to portfolio growth, with June Funds in Use increasing 39% to AU$174 million. Invoice Finance also regained positive momentum. Meanwhile, completion of the company’s platform consolidation is expected to improve scalability, streamline operations and support greater automation.For FY27, Earlypay forecasts underlying NPAT of AU$4.8–AU$5.2 million, implying growth of roughly 30%–40% over FY26. The company also declared a fully franked final dividend of 0.18 cents per share.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Earlypay Enters FY27 with a Larger Lending Portfolio and Growth Momentum
Earlypay Limited (ASX: EPY) ended FY26 with solid portfolio expansion, although increased credit expenses and investment spending pressured profitability. Funds in Use reached AU$307.8 million in June 2026, up 23% year-on-year and marking its strongest level in more than three years. Net revenue increased 7% to AU$36.0 million, while underlying NPAT fell 29% to AU$3.7 million.Equipment Finance was a major contributor to portfolio growth, with June Funds in Use increasing 39% to AU$174 million. Invoice Finance also regained positive momentum. Meanwhile, completion of the company’s platform consolidation is expected to improve scalability, streamline operations and support greater automation.For FY27, Earlypay forecasts underlying NPAT of AU$4.8–AU$5.2 million, implying growth of roughly 30%–40% over FY26. The company also declared a fully franked final dividend of 0.18 cents per share.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au